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In September 2013, dengue virus (DENV) infection was 
diagnosed in a German traveller returning from Japan. 
DENV-specific IgM and IgG and DENV NS1 antigen were 
detected in the patient’s blood, as were DENV serotype 
2-specific antibodies. Public health authorities should 
be aware that autochthonous transmission of this 
emerging virus may occur in Japan. Our findings also 
highlight the importance of taking a full travel history, 
even from travellers not returning from tropical coun-
tries, to assess potential infection risks of patients.
Here we report the clinical and laboratory findings of a 
dengue virus (DENV) infection acquired in Japan in late 
summer 2013 and imported into Germany. 
Case description
A previously healthy woman in her early 50s sought 
treatment in a hospital in Berlin, Germany, in 
September 2013 after returning from travel to Honshu 
Island, Japan. For the previous six days, she had been 
suffering from fever (up to 40 °C) and nausea, followed 
by a maculopapular rash. Laboratory tests on the day 
of admission showed elevated levels of glutamate-
oxalate transaminase (GOT) (96 units (U)/L; norm:  <35 
U/L), glutamate pyruvate transaminase (GPT) (52 U/L; 
norm: <35 U/L), creatine kinase (CK) (553 U/L; norm: 
<170 U/L) and lactate dehydrogenase (LDH) (299 U/L; 
norm: <250 U/L). Leukopenia (white blood cell count: 
3.2 G/L; norm: 4.4–11.3 G/L) was present, which inten-
sified the following day (3.1 G/L). In addition, throm-
bocytopenia, with a platelet count of 87 G/L (norm: 
177–393 G/L) was present, which intensified the fol-
lowing day as well (79 G/L). 
Nine days before admission, she had returned from a 
two-week trip to Japan, during which she visited Ueda, 
Fuefuki, Hiroshima, Kyoto and Tokyo in August. She 
reported several mosquito bites while grape picking in 
Fuefuki. She flew nonstop from Frankfurt International 
Airport to Tokyo Narita International Airport and came 
back the same way. The patient was vaccinated against 
yellow fever in 2009, because she had travelled to 
Kenya that year. In the beginning of 2012, she travelled 
to Singapore. Among several other diseases, dengue 
fever was suspected, because of the clinical picture. 
The first serum sample, collected seven days after 
symptom onset, gave a positive result in DENV IgM 
and IgG antibody tests (in-house indirect immunoflu-
orescence assay (IIFA), according to [1-3]), as well as 
for DENV nonstructural protein-1 (NS1) antigen tested 
by ELISA (Bio-Rad Platelia Dengue NS1 Ag) and a rapid 
test (SD BIOLINE Dengue Duo NS1 Ag + Ab Combo), 
demonstrating an acute DENV infection (Table). Real-
time RT-PCR for DENV RNA [4] and generic flavivirus 
RT-PCR [5] were negative. 
The thrombocytopenia resolved without complications 
and after one week in hospital, the patient was dis-
charged with a characterisation of restitutio ad inte-
grum (restoration to original condition). A follow-up 
serum sample was collected in December 2013, 110 
days after symptom onset, because this acute case of 
dengue fever imported from Japan was considered very 
unusual. This second serum sample revealed a signifi-
cant decrease in DENV IgG titre in the IIFA and negative 
results for DENV NS1 antigen (ELISA and rapid test) and 
DENV IgM (IIFA and rapid test) (Table). In order to iden-
tify the causative DENV serotype, an immune complex 
binding ELISA [6] was performed on the second serum 
sample, demonstrating the presence of DENV serotype 
2-specific antibodies (Table) and the absence of DENV 
serotype 1-, 3- and 4-specific antibodies, thus exclud-
ing a secondary DENV infection.
Background
DENV is an arthropod-borne RNA virus of the Flaviviridae 
family causing dengue fever in humans. Aedes aegypti 
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(Linnaeus) and Ae. albopictus (Skuse) mosquitoes 
are considered to be the main vectors of DENV world-
wide [7]. DENV has emerged in recent decades as a 
worldwide public health problem: current estimations 
assume 390 million DENV infections per year, with 
96 million clinically apparent cases [7]. The virus is 
found in tropical and subtropical regions around the 
world, with hyper-endemic areas in Central and South 
America and in south-east Asia. It is considered an 
emerging threat to Europe because of its detection in 
Croatia (2010) and France (2010 and 2013) [1,8,9]. Ae. 
albopictus is considered to be the potential vector for 
DENV in these countries: it is an invasive species in 
Europe and was recently detected in the south-western 
and south-eastern parts of Germany [10,11]. 
In Germany, dengue fever is notifiable and 870 
imported cases were reported in 2013, with the major-
ity of cases imported from south and south-east Asia 
[12]. There is no evidence for autochthonous transmis-
sion in Germany. 
In Japan, Ae. albopictus is well established and distrib-
uted widely, with its northern limits on Honshu Island 
between latitude 38 ° to 40 ° north [13]. Moreover, Ae. 
aegypti is also invasive in Japan and was detected 
during entomological surveillance at Tokyo Narita 
International Airport in 2012 [14]. The last notable den-
gue fever outbreak in Japan occurred in 1942 to 1945 
in Nagasaki, Kyushu Island, and spread in 1944 to cit-
ies on Honshu Island such as Hiroshima and Osaka 
[15]. This was the most widespread dengue epidemic 
recorded in a temperate region, involving at least 
200,000 cases [16]. It was suggested that the princi-
pal vector was Ae. albopictus [13]. However, no autoch-
thonous cases of dengue infection have been reported 
since 1945 [16]. According to Japanese notification 
data, 249 imported DENV infections were reported in 
2013 [17]. The reported DENV infections were mainly 
caused by DENV serotype 1 [17]. 
Conclusions
This is the first laboratory-confirmed case of DENV 
infection imported from Japan to Germany and, to the 
best of our knowledge, the first recognised case of 
locally acquired DENV infection in Japan for more than 
60 years. Most likely, according to the patient’s activi-
ties and DENV incubation period (3–14 days [18]), the 
infection was acquired in Fuefuki during grape picking. 
However, other possible places of infection cannot be 
entirely ruled out including Tokyo Narita International 
Airport. Thus, we suggest that a viraemic patient was 
bitten by a competent mosquito (most likely Ae. albop-
ictus) in the geographical area where our patient was 
picking fruit, leading to the amplification of DENV sero-
type 2 in the local mosquito population. Such an event 
was probably the source of the virus that infected our 
patient. 
This case adds important epidemiological data that 
can be used to refine DENV risk assessments in Japan. 
Consequently, the Ministry of Health, Labour and 
Welfare of Japan was informed via the International 
Health Regulations National Focal Point about the 
case. Public health authorities, blood transfusion ser-
vices and clinicians in Japan should consider the risk of 
autochthonous DENV infections, especially during the 
summer. Our findings also highlight the importance of 
taking a full travel history, even from travellers who do 
not return from tropical countries, in order to assess 
potential infection risks of the patients [18].
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Table 
Serological results of case of autochthonous dengue virus 
infection in Japan imported into Germany, September 
2013
Antibody or antigen 
tested





DENV NS1b Positive (5.1 arbitrary units)
Negative 
(0.2 arbitrary units)









DENV: dengue virus; JEV: Japanese encephalitis virus; TBEV: tick-
borne encephalitis virus; WNV: West Nile virus; YFV: yellow fever 
virus.
a Indirect immunofluorescence assay (IIFA) titres <1:20 for serum 
were considered negative [1-3]. 
b SD BIOLINE Dengue Duo NS1 Ag + Ab Combo and Bio-Rad Platelia 
Dengue NS1 Ag.  
c Immune complex binding ELISA [6].
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